Circular RNAs in cancer: new insights into functions and implications in ovarian cancer

Zahra Shabaninejad1,2, Asma Vafadar3, Ahmad Movahedpour3,4

  • 1Department of Nanobiotechnology, School of Basic Sciences, Tarbiat Modares University, Tehran, Iran.

Journal of Ovarian Research
|September 5, 2019
PubMed

Insights

Circular RNAs (circRNAs) play a critical role in ovarian cancer by regulating cell proliferation. Their dysregulation is linked to cancer initiation and progression, making them promising biomarkers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are a class of long non-coding RNAs (lncRNAs) with a unique closed-loop structure.
  • They are stable, conserved, and exhibit diverse biological activities, including regulating translation, splicing, and acting as miRNA sponges.
  • circRNAs show tissue and stage-specific expression patterns.

Purpose of the Study:

  • To provide a comprehensive review of current knowledge on circRNAs.
  • To elucidate the pathological roles of circRNAs in ovarian cancer.
  • To highlight the potential of circRNAs as biomarkers and therapeutic targets in ovarian cancer.

Main Methods:

  • Literature review of recent studies on circRNAs and ovarian cancer.
  • Analysis of molecular mechanisms underlying circRNA function in cancer.
  • Synthesis of evidence regarding the association of circRNA dysregulation with ovarian cancer initiation and progression.

Main Results:

  • Circular RNAs are critically involved in various cancer pathogenesis mechanisms, including angiogenesis, apoptosis, growth, and metastasis.
  • In ovarian cancer, circRNAs specifically regulate cell proliferation.
  • Deregulation of circRNAs is associated with the initiation and progression of ovarian cancer.

Conclusions:

  • Circular RNAs are attractive molecules with significant implications in ovarian cancer.
  • They hold potential as reliable cancer biomarkers for early detection and diagnosis.
  • circRNAs represent promising candidates for developing novel therapeutic strategies against ovarian cancer.

Related Concept Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Ovarian cancer metastasis is characterized by numerous diffuse intra-peritoneal lesions, such that accurate visual quantitation of tumor burden is challenging. Herein we describe a method for in situ and ex vivo quantitation of metastatic tumor burden using red fluorescent protein (RFP)-labeled tumor cells and optical...
11.4K
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Tumor-initiating cells (TICs) may represent a viable therapeutic target for the treatment of ovarian cancer, a highly recurrent and fatal disease. We present a protocol for culture conditions that enrich for this highly tumorigenic population of...
14.2K
Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens05:58

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

This study describes a detailed method for isolation and characterization of primary ovarian cancer cells from solid clinical specimens. Ovarian cancer clinical specimens are subjected to enzymatic digestion to obtain viable, fibroblast-free epithelial ovarian cancer (EOC) cells highly suitable for downstream...
14.1K
Use of Alu Element Containing Minigenes to Analyze Circular RNAs13:10

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

We clone and analyze reporter genes generating circular RNAs. These reporter genes are larger than constructs to analyze linear splicing and contain Alu elements. To investigate the circular RNAs, the constructs are transfected into cells and resulting RNA is analyzed using RT-PCR after removal of linear...
7.7K
Functionalized Nanoparticle Targeting of Ovarian Cancer: A Technique to Facilitate Folic Acid-conjugated Nanoparticle Contrast Agent Uptake by Ovarian Cancer Cells02:53

Functionalized Nanoparticle Targeting of Ovarian Cancer: A Technique to Facilitate Folic Acid-conjugated Nanoparticle Contrast Agent Uptake by Ovarian Cancer Cells

In this video, we demonstrate a technique to facilitate the internalization of folic acid-capped copper sulfide nanoparticles (CuS NPs). Folic acid-functionalized CuS NPs have the ability to target folate-receptors which are overexpressed in many ovarian cancer...
3.3K
Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis11:51

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

This article presents a protocol of differential-speed centrifugation in combination with density gradient centrifugation to separate mitochondria from human ovarian cancer tissues and control ovarian tissues for quantitative proteomics analysis, resulting in a high-quality mitochondrial sample and high-throughput and high-reproducibility quantitative proteomics analysis of a human ovarian cancer mitochondrial...
6.3K